|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
1991-4-22
|
|
pubmed:abstractText |
The plasma concentration of lipoprotein (a) [Lp(a)] is correlated with the risk of atherosclerosis. It is a lipoprotein particle consisting of apoprotein (a) [Lp(a)] is correlated with the risk of atherosclerosis. It is a lipoprotein particle consisting of apoprotein (a) [apo(a)], a protein showing considerable amino acid sequence identity with plasminogen. bound to low-density lipoprotein. The apo(a) portion of Lp(a) was recently shown to have serine-proteinase-type amidolytic activity and to be able to degrade the adhesive glycoprotein fibronectin. To characterize this enzyme activity further, we used chromogenic peptide substrates and inhibitors. Of the substrates tested, those with arginine at the scissile bond [N-alpha-benzoyl-L-Arg p-nitroanilide (pNA), N-alpha-benzoyl-Ile-Glu-Gly-Arg-pNA, N-alpha-benzyloxycarbonyl-Arg-Gly-Arg-pNA] gave the highest hydrolysis rates. Synthetic substrates with plasmin specificity (Val-Leu-L-Lys-pNA and Val-Phe-L-Lys-pNA) were not hydrolysed by Lp(a). Neither tissue plasminogen activator nor urokinase had any effect on the enzyme activity. The addition of antibodies to these plasminogen activators did not inhibit the enzyme activity of Lp(a). Inhibition experiments with phenylmethanesulphonyl fluoride, carbodi-imide, dichloroisocoumarin and competitive peptide inhibitors demonstrated that Lp(a) has enzyme activity that closely resembles that of serine proteinases. Whether this serine-proteinase activity of Lp(a) plays any role in the genesis of atherosclerosis remains to be established.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-1012021,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-13252080,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-14064818,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-14907713,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-2521477,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-2524666,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-2528948,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-2531657,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-2644074,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-2665806,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-2925643,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-2933479,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-2945939,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-2948513,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-2956279,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-2962926,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-2969235,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-332063,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-3410459,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-3442597,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-3472206,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-3670400,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-3893537,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-4340182,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-4369735,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-4821870,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-4991520,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-4998784,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-5275982,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-5763076,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-5764436,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-6210828,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-6219896,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-6220008,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-6450468,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-73215,
http://linkedlifedata.com/resource/pubmed/commentcorrection/1826080-7470205
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0264-6021
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
274 ( Pt 2)
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
491-6
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:1826080-Amino Acid Sequence,
pubmed-meshheading:1826080-Apolipoproteins,
pubmed-meshheading:1826080-Chromatography, Affinity,
pubmed-meshheading:1826080-Chromatography, Gel,
pubmed-meshheading:1826080-Endopeptidases,
pubmed-meshheading:1826080-Humans,
pubmed-meshheading:1826080-Hydrolysis,
pubmed-meshheading:1826080-Indicators and Reagents,
pubmed-meshheading:1826080-Kinetics,
pubmed-meshheading:1826080-Lipoprotein(a),
pubmed-meshheading:1826080-Lipoproteins,
pubmed-meshheading:1826080-Molecular Sequence Data,
pubmed-meshheading:1826080-Oligopeptides,
pubmed-meshheading:1826080-Substrate Specificity
|
|
pubmed:year |
1991
|
|
pubmed:articleTitle |
Characterization of the enzyme activity of human plasma lipoprotein (a) using synthetic peptide substrates.
|
|
pubmed:affiliation |
National Public Health Institute, Mannerheimintie, Helsinki.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
